<DOC>
	<DOC>NCT02502656</DOC>
	<brief_summary>This study will evaluate the concordance of RAS mutation detection between the results obtained from circulating tumor DNA and those obtained with the "standard" method (testing from tumor tissue).</brief_summary>
	<brief_title>RAS Mutation Testing in the Circulating Blood of Patients With Metastatic Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Pathologically confirmed metachronous or synchronous metastatic colorectal cancer No prior chemotherapy with the exception of adjuvant chemotherapy completed â‰¥ 6 months prior to enrollment Signed written informed consent obtained prior to any study specific screening procedures Patients willing to provide a blood sample for Translational Research No tumor block available Previous malignancy in the last 5 years Medical, sociological, psychological or legal conditions that would not permit the patient to sign informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>RAS mutation</keyword>
	<keyword>DNA</keyword>
	<keyword>Colorectal Cancer</keyword>
</DOC>